DEVIATION WRITING 101
A Practical Guide to Crafting Clear, Compliant cGMP Investigations that Meet FDA and Global Regulatory Expectations
Deviation Writing 101 provides a clear and authoritative roadmap for deviation management as it utilizes a holistic approach that empowers quality professionals with a profound understanding of the foundational principles that underpin every successful investigation. The book meticulously defines the types of deviations and provides a structured lifecycle—from immediate actions to final approval; ensuring that deviation writers are not just completing a task but builds a robust and compliant quality system through a defined methodology.
This book serves as a comprehensive guide with a detailed framework to understanding, investigating, and resolving these deviations by proactively identifying their root causes, and implementing robust corrective actions. Drawing on industry best practices, established methodologies, and real-world examples, this book will equip quality professionals, investigators, and managers with a resource guide to conduct thorough, compliant, and defensible deviation investigations.
This is more than a manual; it is a testament to the belief that you, as a quality professional, must be a master of your craft, equipped with the knowledge to make objective, defensible decisions, while ensuring patient safety and regulatory compliance. You’ll never look at a deviation the same way again.
About the Author
Damion D. Josephs is a highly accomplished and dedicated veteran of the biopharma industry, bringing over a decade of hands-on, multi-faceted experience to the realm of pharmaceutical manufacturing and quality assurance. Damion has built his career on a deep foundation of Current Good Manufacturing Practice (cGMP) principles. His experience spans critical operational roles, including a significant tenure as a production supervisor where he was directly responsible for:
• Leading and mentoring cross-functional production teams.
• Optimizing batch record execution and reducing cycle times for key drug products.
• Ensuring strict adherence to all regulatory guidelines during all phases of cGMP manufacturing.
Damion’s expertise is not confined to a single facility; he has served as a critical resource across international sites. This global exposure has equipped him with a profound understanding of harmonizing quality standards across different global regulatory bodies and navigating diverse cultural and operational environments.
Furthermore, his academic background, which includes an MBA, provides him with the strategic and business acumen to link quality initiatives directly to organizational goals, ensuring that compliance efforts are both robust and economically sound. Above all, Josephs is a steadfast problem solver and a highly skilled professional whose dedication is focused on two nonnegotiable outcomes: ensuring product quality and patient safety on a global scale. He is recognized by peers and leadership for his unwavering integrity, attention to detail, and ability to translate complex technical issues into clear, actionable strategies.
Yet, Damion’s world extends far beyond the disciplined realm of science and engineering. He is a devoted family man, married to his wife, Toy Josephs, and a proud father to Princess Deborah, Prince Damion Jr., King Daniel, and the doting grandparents of Jayce King. At his core, he is a man of profound faith, a servant and slave of Christ, who finds purpose and passion in prayer, praise, and preaching.
A native of Jamaica, now residing in Wichita, Kansas, he blends the vibrant flavors of his homeland into savory Jamaican dishes and natural juices. He finds a different rhythm in the soulful cadence of his electric bass and the raw emotion of his unpublished anthology, Echoes from the Heart. A former undergraduate instructor in leadership and business management, and an avid sports enthusiast who played varsity soccer and ran track and field, Damion embodies a unique fusion of technical excellence and a deep appreciation for life, art, knowledge, and the richness of different cultures.
DEVIATION WRITING 101
A Practical Guide to Crafting Clear, Compliant cGMP Investigations that Meet FDA and Global Regulatory Expectations
Chapter 1: Types of Deviations
Deviations are inevitable in GMP manufacturing, requiring risk-based classification to protect patient safety.
Chapter 2: Investigation Methodologies
Structured investigation methodologies are employed to move beyond superficial symptoms to identify and resolve the true systemic root cause of a deviation.
Chapter 3: Data Collection
Defensible investigations must transition from subjective opinion to objective, fact-based inquiry.
Chapter 4: Immediate Actions
Immediate steps focus on containment, correction, and formalizing the investigation.
Chapter 5: Impact Assessments
Impact assessments utilize risk matrices to evaluate effects on SISPQ, ultimately determining the final disposition of the product and the necessary scope of the CAPA plan.
Chapter 6: Defining the Scope of the Deviation
Precise scope definition is essential for creating a focused and auditable investigation.
Chapter 7: Historical Reviews and Complaints
Historical reviews determine whether an event is isolated or a recurring systemic trend.
Chapter 8: Training Review
Training reviews investigate systemic failures rather than simply blaming individuals.
Chapter 9: Conducting Interviews for GMP Investigations
Interviews serve as fact-finding missions built on trust to uncover the “why” behind a deviation that automated records often miss.
Chapter 10: Investigation Write-Up
Investigation write-ups must be clear, professional, and adhere to ALCOA+ principles.
Chapter 11: Due Date Extensions
Due date extensions require tiered justification and cross-functional oversight.
Chapter 12: Regulatory Agencies, LIRs, SCARs, FARs, OOS, OOE, OOT, OOC, and OOL
Compliance is maintained through formal management of the investigation types to maintain a state of control and public trust.
Chapter 13: CAPAs, Effectiveness Checks, and Change Controls (CC)
CAPAs and Change Controls ensure systemic issues are permanently resolved.
Chapter 14: Investigation Review and Approval
Multi-tiered reviews by SMEs and QA ensure technical and regulatory validity.
Chapter 15: Preparing for Audits
Audit readiness requires a proactive state of continuous compliance and documentation.
Chapter 16: Implications of AI and Writing cGMP Deviation Investigations
AI can expedite investigations but requires human accountability for critical judgment.


